Top Abstract Purchase Related
Home
>
Node
>
Subnode

The lupus anticoagulant and antiphospholipid antibodies

Pertusi, R.M.

Journal of the American Osteopathic Association 92(8): 1021-1025

1992

ISSN/ISBN: 0098-6151
PMID: 1429061
Document Number: 397503
Antiphospholipid antibody syndromes are primarily manifested as unexplained thrombotic events. Several antiphospholipid antibodies have been identified, the lupus anticoagulant being the most recognized. Considerable confusion surrounds this "anticoagulant," which is highly correlated with an increased risk of thrombosis. Several assays have been designed for the detection of antiphospholipid antibodies. There are limitations on their efficacy and interpretation requires judgement. Treatment strategies for the clinical manifestations of the antiphospholipid antibody syndrome are being developed. The explosive rise in the volume of literature dedicated to this topic will assure new and improved modalities for evaluation and treatment.

Document emailed within 1 workday
Secure & encrypted payments

Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924
Alarcon-Segovia, D.; Mestanza, M.; Cabiedes, J.; Cabral, A.R. 1997: The antiphospholipid/cofactor syndromes. II. a variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein i but no antibodies detectable in standard antiphospholipid assays Journal of Rheumatology 24(8): 1545-1551
Brandt, J.T.; Triplett, D.A.; Alving, B.; Scharrer, I. 1995: Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH Thrombosis and Haemostasis 74(4): 1185-1190
Wisløff, F.; Sletnes, K.; Godal, H.C. 1990: Antiphospholipid syndrome and lupus anticoagulant Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(1): 94
Malaviya, A.N. 1991: Lupus anticoagulant, anticardiolipin antibody or antiphospholipid syndrome? Journal of the Association of Physicians of India 39(3): 239-241
D'Cruz, D.P.; Mellor-Pita, S.; Joven, B.; Sanna, G.; Allanson, J.; Taylor, J.; Khamashta, M.A.; Hughes, G.R.V. 2004: Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies Journal of Rheumatology 31(2): 280-285
Natejumnong, C.; Ruangkanchanasetr, P.; Aimpun, P.; Supaporn, T. 2006: Significance of antiphospholipid antibodies in lupus nephritis Journal of the Medical Association of Thailand 89(Suppl 2): S121-S128
Falcao, C.A.; Alves, I.C.; Chahade, W.H.; Duarte, A.L.B.P.; Lucena-Silva, N. 2002: Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus Arquivos Brasileiros de Cardiologia 79(3): 285-291
Levy, R.A.; Gharavi, A.E.; Sammaritano, L.R.; Habina, L.; Qamar, T.; Lockshin, M.D. 1990: Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis Journal of Rheumatology 17(8): 1036-1041
Fijnheer, R.; Horbach, D.A.; Donders, R.C.; Vilé, H.; von Oort, E.; Nieuwenhuis, H.K.; Gmelig-Meijling, F.H.; de Groot, P.G.; Derksen, R.H. 1996: Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus Thrombosis and Haemostasis 76(4): 514-517
Gil, A.; Khamashta, M.; Lavilla, P.; Valencia, M.E.; Pintado, V.; López Dupla, J.M. 1989: Acute cerebral organic syndrome, systemic lupus erythematosus and antiphospholipid antibodies Anales de Medicina Interna 6(3): 167
Corbella, X.; Mitjavila, F.; Campoy, E.; Saez, A.; Moga, I.; Vidaller, A. 1994: Chronic ascites in late onset systemic lupus erythematosus with antiphospholipid antibodies Journal of Rheumatology 21(6): 1141-1143
Harel, L.; Sandborg, C.; Lee, T.; von Scheven, E. 2006: Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies Journal of Rheumatology 33(9): 1873-1877
Rafai, M.A.; Fadel, H.; Boulaajaj, F.Z.; Gam, I.; El-Moutawakkil, B.; Karkouri, M.; Hakim, K.; Slassi, I. 2007: Peripheral neuropathy in systemic lupus erythematosus with epineural vasculitis and antiphospholipid antibodies Revue Neurologique (Paris) 163(1): 103-106
Dungan, D.D.; Jay, M.S. 1992: Stroke in an early adolescent with systemic lupus erythematosus and coexistent antiphospholipid antibodies Pediatrics 90(1 Part 1): 96-99
Pattison, N.S.; McKay, E.J.; Liggins, G.C.; Lubbe, W.F. 1987: Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy New Zealand Medical Journal 100(817): 61-64
Hosaka, K.; Okada, J.; Ogiwara, A.; Kobayashi, A.; Kondo, H. 1994: Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus Ryumachi 34(1): 22-29
Satoh, A.; Suzuki, K.; Takayama, E.; Kojima, K.; Hidaka, T.; Kawakami, M.; Matsumoto, I.; Ohsuzu, F. 1999: Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus Journal of Rheumatology 26(8): 1715-1720
Molta, C.; Meyer, O.; Dosquet, C.; Montes de Oca, M.; Babron, M.C.; Danon, F.; Kaplan, C.; Clémenceau, S.; Castellano, F.; Levy, M. 1993: Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives Pediatrics 92(6): 849-853